ClearanceBrief
Recall Z-0239-2016 ยท DHX System, Test, Carcinoembryonic Antigen

Beckman Coulter Inc.

Access CEA Assay, Part No. 33200. For the quantitative determination of Carcinoembryonic Antigen (CEA) levels in human serum.

DateNov 6, 2015 (initiated Oct 13, 2015)
StatusTerminated
ReasonBeckman Coulter is recalling the Access CEA reagent packs because they were filled incorrectly.
Root causeUnder Investigation by firm
ActionAn Urgent Medical Device Recall letter dated 10/13/15 was sent to all customers who purchased the Access CEA Reagent Kit to inform them that Beckman Coulter has determined that the Access CEA reagent packs (P/N 33200) were filled incorrectly. The packs contain insufficient quantity of reagents in one of the pack wells. The letter informs the customers of the impact and the actions to be taken. Customers are instructed to complete and return the enclosed response form within 10 days. Customers with questions are instructed to contact Beckman Coulter's Customer Technical Support at http://ww
Quantity11,406 units total (1,660 units)
DistributionWorldwide Distribution-US (nationwide) and the countries of Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czech Republic, Egypt, France, Germany, Ghana, Gibraltar, Greece, Guam, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Republic of Korea, Lebanon, Mex
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K031270ACCESS CEA REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY SYSTEMS
Beckman Coulter, Inc., May 6, 2003